Back to the registry
Agent passport

PharmaWise AI

L&T Technology Services · Intelligence & Research

SaaSNo attestation published

Certification per Microsoft Marketplace.

pharma R&D ELN AIGxP reports
Provenance reach3 of 12 layers traced

Evidence tier Source Confirmed · 8 captures on record

User ratingNot rated0 reviews on the listing
Runs onSaaSSaaS
ProvenanceUnknown33% of the provenance layers this product can disclose
Evidence riskHighSign in to see the basis for this band.

What the publisher says

As described on Microsoft Marketplace.

PharmaWise AI: The Intelligence Layer for R&D

PharmaWise AI is an advanced, AI-powered platform designed to transform and accelerate pharmaceutical research and development by serving as an intelligent overlay across your existing systems. Built to integrate seamlessly with tools such as BIOVIA, LabWare, Empower, Plate Readers, ERP systems, ELN, and LIMS, the platform connects fragmented data sources into a unified, GxP-ready ecosystem.

Show the rest of the publisher’s description (9 more lines)

At its core, PharmaWise AI enhances how scientists, researchers, and compliance teams interact with data. It eliminates traditional silos by enabling intuitive, AI-driven access to complex datasets without requiring deep technical expertise. By doing so, it empowers users to focus more on scientific innovation rather than operational overhead.

One of the platform’s standout capabilities is its interactive dashboards, which provide real-time visualization of key metrics such as project progress, experiment throughput, and compliance status. These dashboards aggregate data from multiple systems to deliver actionable insights, enabling teams to monitor performance and make informed decisions quickly.

PharmaWise AI also includes automated report generation, significantly reducing the manual effort involved in documentation. The system can generate detailed textual summaries and rich, multi-format reports by pulling information from internal records as well as external databases like PubMed and FDA repositories. This ensures that outputs are both comprehensive and up-to-date.

To address regulatory requirements, the platform features a powerful Compliance Assistant. Users can ask compliance-related questions, validate projects against internal and regulatory documents, and upload new guidelines or policies. This intelligent assistant simplifies regulatory navigation and ensures that all processes remain aligned with industry standards and GxP requirements.

The Project and Experiment Notebook acts as a centralized hub, offering a holistic view of projects. It consolidates experiments, sample data, results, and associated documentation into a single interface, improving traceability and collaboration across teams.

Another key feature is template-driven documentation, which accelerates the creation of standard reports such as ICH Q2(R1) and SOPs. These pre-built templates ensure consistency, reduce errors, and save valuable time in routine documentation tasks.

The platform’s benefits are substantial. By automating repetitive activities such as data retrieval, analysis, and reporting, PharmaWise AI significantly accelerates research timelines. It enhances data accessibility, allowing users at all levels to extract insights without needing SQL or advanced technical skills. This democratization of data improves cross-functional collaboration and transparency.

Furthermore, PharmaWise AI strengthens decision-making by delivering instant, data-driven insights through dashboards and natural language queries. It also simplifies compliance management, enabling on-demand access to regulatory information while ensuring consistent adherence to standards.

Overall, PharmaWise AI drives operational efficiency by streamlining workflows, reducing manual effort, and integrating critical R&D systems into a cohesive intelligence layer. By doing so, it positions organizations to innovate faster, remain compliant, and achieve higher productivity across the pharmaceutical lifecycle.

Preview

2 images
PharmaWise AI preview 1PharmaWise AI preview 2

Agent build and provenance

See the full provenance

The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.

Compliance

Government
  • FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27

Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.

Vendor

External enrichment · as of 2026-08-03

CompanyL&T Technology Services LimitedAutomated
HQIndiaAutomated
IndustryTechnologyAutomated
Websitehttps://www.ltts.com/

Sources

Marketplace listingmarketplace.microsoft.comSource
Privacy PolicyPrivacy PolicySource

Publisher resources

1 link
Supportwww.ltts.comSource

Linked repositories

RepositoriesUnknownUnknown

Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.

Pricing
Unknown
Not stated
Delivery
SaaS
https://www.ltts.com/
Open the source listing ↗

Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.